Timolol plus maximum-tolerated antiglaucoma therapy.
D000328:Adult; D000368:Aged; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010277:Parasympathomimetics / Q000627:therapeutic use; D010919:Placebos; D011412:Propanolamines / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use*
D002257:Carbonic Anhydrase Inhibitors; D010277:Parasympathomimetics; D010919:Placebos; D011412:Propanolamines; D013566:Sympathomimetics; D013999:Timolol